These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11114225)

  • 1. Renal tubular acidosis associated with zonisamide therapy.
    Inoue T; Kira R; Kaku Y; Ikeda K; Gondo K; Hara T
    Epilepsia; 2000 Dec; 41(12):1642-4. PubMed ID: 11114225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubular acidosis associated with zonisamide therapy in a dog.
    Cook AK; Allen AK; Espinosa D; Barr J
    J Vet Intern Med; 2011; 25(6):1454-7. PubMed ID: 22092642
    [No Abstract]   [Full Text] [Related]  

  • 3. Topiramate-induced metabolic acidosis: a case study.
    Fernández-de Orueta L; Esteban-Fernández J; Aichner HF; Casillas-Villamor A; Rodríguez-Álvarez S
    Nefrologia; 2012 May; 32(3):403-4. PubMed ID: 22592431
    [No Abstract]   [Full Text] [Related]  

  • 4. IgA and IgG2 deficiency associated with zonisamide therapy: a case report.
    Maeoka Y; Hara T; Dejima S; Takeshita K
    Epilepsia; 1997 May; 38(5):611-3. PubMed ID: 9184608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal renal tubular acidosis and lethargy associated with zonisamide treatment in a dog with idiopathic epilepsy.
    Itoi T; Akashi N; Shimizu Y; Sugimoto K; Hata A; Kutara K; Miyama TS; Kanda T
    Vet Med Sci; 2022 Nov; 8(6):2256-2260. PubMed ID: 35916390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.
    Mirza NS; Alfirevic A; Jorgensen A; Marson AG; Pirmohamed M
    Pharmacogenet Genomics; 2011 May; 21(5):297-302. PubMed ID: 21278619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Othello syndrome secondary to zonisamide].
    Rubio-Nazabal E; Alvarez-Pérez P; Lema-Facal T; López-Facal S
    Med Clin (Barc); 2014 Feb; 142(3):133-4. PubMed ID: 23664689
    [No Abstract]   [Full Text] [Related]  

  • 10. Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation.
    Ikeda A; Hattori H; Odani A; Kimura J; Shibasaki H
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):803-4. PubMed ID: 9810971
    [No Abstract]   [Full Text] [Related]  

  • 11. Zonisamide approved for partial seizures.
    Am J Health Syst Pharm; 2000 May; 57(9):834, 837. PubMed ID: 10840516
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two epileptics showing antiepileptic drug-induced psychoses.
    Tsuji M; Hori S; Asai N; Hamanaka T; Ishikawa T; Hiyoshi T; Mochizuki H
    Jpn J Psychiatry Neurol; 1993 Jun; 47(2):298-9. PubMed ID: 8271571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Zonisamide as add-on treatment for focal epilepsies. An outcome analysis of 74 patients].
    Wellmer S; Wellmer J; Bauer J
    Nervenarzt; 2008 Dec; 79(12):1416, 1418-23. PubMed ID: 18633587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide-induced suicidal ideation.
    Mago R; Huege S; Ahuja N; Kunkel EJ
    Psychosomatics; 2006; 47(1):68-9. PubMed ID: 16384810
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of life in patients with partial-onset seizures under adjunctive therapy with zonisamide: results from a prospective non-interventional surveillance study.
    Helmstaedter C; Stefan H; Witt JA
    Epileptic Disord; 2011 Sep; 13(3):263-76. PubMed ID: 21914589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal Renal Tubular Acidosis Screening by Urinary Acidification Testing in Mexican Children.
    Guerra-Hernández NE; Ordaz-López KV; Escobar-Pérez L; Gómez-Tenorio C; García-Nieto VM
    Rev Invest Clin; 2015; 67(3):191-8. PubMed ID: 26202743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide: a review of its use in the management of partial seizures in epilepsy.
    Frampton JE; Scott LJ
    CNS Drugs; 2005; 19(4):347-67. PubMed ID: 15813651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.